Valsartan Lawsuit Lawyer

Valsartan Class Actions & Individual Lawsuits

Valsartan lawsuits have been springing up across the country in relation to injuries allegedly caused by the drug used to treat high blood pressure and heart failure. A valsartan class action lawsuit has been filed against several sellers and the manufacturer as well. If you or a loved one has developed cancer you suspect is a result of the use of valsartan (a/k/a Diovan), you should consult a valsartan lawsuit lawyer regarding your rights today. You may be entitled to legal compensation.

On July 17, 2018, the FDA issued a press release announcing the voluntary recall of “several drug products containing the active ingredient valsartan.” The announcement was in response to the discovery of N-nitrosodimethylamine (NDMA), a carcinogen found in the recalled products. The American Cancer Association defines carcinogens as substances and exposures that can lead to cancer.

At the time of the recall, over 1.5 million Americans were using valsartan daily. If you or someone you love was diagnosed with cancer after taking valsartan, consult an experienced products liability attorney today. At Simmons and Fletcher, P.C., we provide free case evaluations for individuals who have suffered injuries due to the negligence of another party. Call us at 800-298-0111 or chat with us below.

What is Valsartan?

Valsartan is an oral medication given to patients with high blood pressure, heart failure or patients who have had a heart attack. Valsartan is an angiotensin II receptor antagonist; which is a class of medication that works by blocking the action of certain natural substances that tighten the blood vessels, ultimately relaxing the blood vessels and putting less strain on the heart.

What is NDMA?

N-Nitrosodimethylamine (NDMA) is a byproduct of many industrial manufacturing processes including manufacturing of unsymmetrical dimethylhydrazine (UDMH), which is a component of rocket fuel that requires NDMA for its synthesis. It is classified as a B2 carcinogen–meaning it is known to cause cancer in animals and a probable cause of cancer in humans. Trace amounts can be found in some foods such as bacon. However, the trace amounts are not believed to be harmful.

How Did NDMA Get into Valsartan?

Novartis was the original manufacturer and patent holder for valsartan. They also obtained FDA approval for their processes. After the patent expires on a drug, other companies can make it as a generic. It is believed that around 2012, the synthesis process used by generic manufacturers was updated and that this change resulted in a side-reaction occurring that resulted in elevated levels of NDMA being produced.

FDA Issues Voluntary Recall on Valsartan Products

The product manufacturers listed in the recall include:

  • Major Pharmaceuticals
  • Solco Healthcare
  • Teva Pharmaceuticals Industries Ltd.

In addition to valsartan, Solco Healthcare and Teva Pharmaceuticals Industries Ltd., must also recall their valsartan/hydrochlorothiazide (HCTZ) medication. “We have carefully assessed the valsartan-containing medications sold in the United States, and we’ve found that the valsartan sold by these specific companies does not meet our safety standards. This is why we’ve asked these companies to take immediate action to protect patients,” said Janet Woodcock, M.D., director of the FDA’s Center for Drug Evaluation and Research.

Here is a list of recalled valsartan medications published by the FDA on March 22, 2019.

Injuries Associated with Valsartan

The link between valsartan and several types of cancer and organ damage is under investigation. This list of potential damage includes:

  • Liver Injury & Failure
  • Stomach Cancer
  • Pancreatic Cancer
  • Kidney Injury
  • Colorectal Cancer
  • Bowl Cancer

If you have taken valsartan for an extended period of time and then been diagnosed with an of those types of cancer or liver or kidney damage, you may have a claim for compensation.

Lawyers for Valsartan Injury Claims

Currently, there have been numerous lawsuits filed across the country alleging that valsartan caused a patient’s cancer or liver damage.  The Federal lawsuits have been consolidated into MDL 19-2875 in the United States District Court for the District of New Jersey Camden Vicinage before Judge Robert B. Kugler.  Call Simmons and Fletcher, P.C. to get connected with an attorney investigating valsartan today if you have been diagnosed with lung, liver, or kidney cancer after prolonged use of valsartan.

More Reading on the Valsartan Litigation:

Valsartan Recall News
Related Litigation: Losartan

Warning: Never discontinue taking any prescribed medication without consulting your licensed physician.

Spread the love


Paul Cannon

Paul Cannon has practiced personal injury trial law since 1995. He is Board Certified in Personal Injury Trial Law (2005). He has earned recognition as a Super Lawyer by Thompson Reuters in 2017 & 2018, and as a Top 100 Trial Lawyer by the National Trial Lawyers Association in 2017. He is a Shareholder, trial lawyer and online marketing manager at Simmons and Fletcher, P.C. His legal writings have been published by the Texas Bar Journal,, HG Legal Resources,, and others. He has been asked to give education talks and media interviews on dog bite law.